Zhejiang Hisun Pharmaceutical Co Ltd (600267) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥438.43 Million ≈ $64.16 Million USD) by net assets (CN¥8.76 Billion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Hisun Pharmaceutical Co Ltd (600267) net asset quality to measure how much of total assets are equity-financed.
Zhejiang Hisun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Zhejiang Hisun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600267 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Hisun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Hisun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Diamondrock Hospitality Company Common Stock
NYSE:DRH
|
0.015x |
|
Sino-Platinum Metals Co Ltd
SHG:600459
|
-0.104x |
|
OEM International AB (publ)
ST:OEM-B
|
0.095x |
|
ChipMOS Technologies
TW:8150
|
0.013x |
|
Energa S.A.
WAR:ENG
|
0.085x |
|
Inari Amertron Bhd
KLSE:0166
|
0.027x |
|
Northwest Bancshares Inc
NASDAQ:NWBI
|
0.039x |
|
Xinxing Ductile Iron Pipes Co Ltd
SHE:000778
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Zhejiang Hisun Pharmaceutical Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.85 Billion ≈ $1.30 Billion |
CN¥2.03 Billion ≈ $297.30 Million |
0.230x | -6.88% |
| 2024-12-31 | CN¥8.58 Billion ≈ $1.26 Billion |
CN¥2.11 Billion ≈ $309.42 Million |
0.246x | +35.66% |
| 2023-12-31 | CN¥8.35 Billion ≈ $1.22 Billion |
CN¥1.52 Billion ≈ $221.98 Million |
0.182x | -26.73% |
| 2022-12-31 | CN¥8.33 Billion ≈ $1.22 Billion |
CN¥2.07 Billion ≈ $302.28 Million |
0.248x | +4.90% |
| 2021-12-31 | CN¥7.35 Billion ≈ $1.07 Billion |
CN¥1.74 Billion ≈ $254.11 Million |
0.236x | +22.79% |
| 2020-12-31 | CN¥8.26 Billion ≈ $1.21 Billion |
CN¥1.59 Billion ≈ $232.61 Million |
0.193x | +111.79% |
| 2019-12-31 | CN¥7.68 Billion ≈ $1.12 Billion |
CN¥698.39 Million ≈ $102.20 Million |
0.091x | -53.62% |
| 2018-12-31 | CN¥7.38 Billion ≈ $1.08 Billion |
CN¥1.45 Billion ≈ $211.64 Million |
0.196x | +24.42% |
| 2017-12-31 | CN¥7.88 Billion ≈ $1.15 Billion |
CN¥1.24 Billion ≈ $181.55 Million |
0.158x | +63.23% |
| 2016-12-31 | CN¥8.04 Billion ≈ $1.18 Billion |
CN¥775.90 Million ≈ $113.54 Million |
0.097x | +7.05% |
| 2015-12-31 | CN¥8.17 Billion ≈ $1.19 Billion |
CN¥736.17 Million ≈ $107.72 Million |
0.090x | +30.49% |
| 2014-12-31 | CN¥8.26 Billion ≈ $1.21 Billion |
CN¥571.04 Million ≈ $83.56 Million |
0.069x | -21.92% |
| 2013-12-31 | CN¥5.96 Billion ≈ $871.87 Million |
CN¥527.25 Million ≈ $77.15 Million |
0.088x | +22.41% |
| 2012-12-31 | CN¥5.20 Billion ≈ $760.59 Million |
CN¥375.75 Million ≈ $54.98 Million |
0.072x | -36.79% |
| 2011-12-31 | CN¥4.59 Billion ≈ $672.18 Million |
CN¥525.31 Million ≈ $76.87 Million |
0.114x | -38.37% |
| 2010-12-31 | CN¥2.74 Billion ≈ $401.57 Million |
CN¥509.18 Million ≈ $74.51 Million |
0.186x | -4.62% |
| 2009-12-31 | CN¥2.43 Billion ≈ $355.67 Million |
CN¥472.85 Million ≈ $69.19 Million |
0.195x | +36.20% |
| 2008-12-31 | CN¥1.55 Billion ≈ $226.70 Million |
CN¥221.28 Million ≈ $32.38 Million |
0.143x | -55.07% |
| 2007-12-31 | CN¥1.38 Billion ≈ $201.50 Million |
CN¥437.72 Million ≈ $64.05 Million |
0.318x | +273.86% |
| 2006-12-31 | CN¥1.27 Billion ≈ $185.92 Million |
CN¥108.03 Million ≈ $15.81 Million |
0.085x | -8.03% |
| 2005-12-31 | CN¥1.23 Billion ≈ $179.69 Million |
CN¥113.53 Million ≈ $16.61 Million |
0.092x | -64.49% |
| 2004-12-31 | CN¥1.20 Billion ≈ $175.90 Million |
CN¥312.93 Million ≈ $45.79 Million |
0.260x | -9.59% |
| 2003-12-31 | CN¥1.00 Billion ≈ $146.59 Million |
CN¥288.45 Million ≈ $42.21 Million |
0.288x | +96.58% |
| 2002-12-31 | CN¥824.83 Million ≈ $120.70 Million |
CN¥120.82 Million ≈ $17.68 Million |
0.146x | +66.14% |
| 2001-12-31 | CN¥784.18 Million ≈ $114.75 Million |
CN¥69.14 Million ≈ $10.12 Million |
0.088x | +19.97% |
| 2000-12-31 | CN¥757.90 Million ≈ $110.90 Million |
CN¥55.70 Million ≈ $8.15 Million |
0.073x | -43.75% |
| 1999-12-31 | CN¥249.88 Million ≈ $36.56 Million |
CN¥32.64 Million ≈ $4.78 Million |
0.131x | -- |
About Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small mol… Read more